Phosphatases and solid tumors: focus on glioblastoma initiation, progression and recurrences

被引:16
作者
Dedobbeleer, Matthias [1 ]
Willems, Estelle [1 ]
Freeman, Stephen [2 ]
Lombard, Arnaud [1 ,3 ,4 ]
Goffart, Nicolas [4 ,5 ,6 ,7 ]
Rogister, Bernard [1 ,4 ,8 ]
机构
[1] Univ Liege, GIGA Neurosci Res Ctr, Lab Nervous Syst Disorders & Therapy, Liege, Belgium
[2] Univ Liege, GIGA Neurosci Res Ctr, Lab Dev Neurobiol, Liege, Belgium
[3] CHU, Dept Neurosurg, Liege, Belgium
[4] Univ Liege, Liege, Belgium
[5] CHU, Human Genet, Liege, Belgium
[6] Brain Ctr Rudolf Magnus Inst Neurosci, Dept Neurosurg, Utrecht, Netherlands
[7] Univ Med Ctr, T&P Bohnenn Lab Neurooncol, Utrecht, Netherlands
[8] CHU, Dept Neurol, Liege, Belgium
关键词
DUAL-SPECIFICITY PHOSPHATASE; PROTEIN-KINASE PHOSPHATASE-1; HUMAN OVARIAN-CANCER; CELL LUNG-CANCER; INTEGRATED GENOMIC ANALYSIS; SIGNAL-REGULATED KINASE; NEGATIVE BREAST-CANCER; HIGH-GRADE GLIOMA; STEM-LIKE CELLS; PROSTATE-CANCER;
D O I
10.1042/BCJ20170112
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Phosphatases and cancer have been related for many years now, as these enzymes regulate key cellular functions, including cell survival, migration, differentiation and proliferation. Dysfunctions or mutations affecting these enzymes have been demonstrated to be key factors for oncogenesis. The aim of this review is to shed light on the role of four different phosphatases (PTEN, PP2A, CDC25 and DUSP1) in five different solid tumors (breast cancer, lung cancer, pancreatic cancer, prostate cancer and ovarian cancer), in order to better understand the most frequent and aggressive primary cancer of the central nervous system, glioblastoma.
引用
收藏
页码:2903 / 2924
页数:22
相关论文
共 241 条
[1]   Glioblastoma: pathology, molecular mechanisms and markers [J].
Aldape, Kenneth ;
Zadeh, Gelareh ;
Mansouri, Sheila ;
Reifenberger, Guido ;
von Deimling, Andreas .
ACTA NEUROPATHOLOGICA, 2015, 129 (06) :829-848
[2]   miRNA Regulation in Gliomas: Usual Suspects in Glial Tumorigenesis and Evolving Clinical Applications [J].
Ames, Heather ;
Halushka, Marc K. ;
Rodriguez, Fausto J. .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2017, 76 (04) :246-254
[3]  
[Anonymous], J CARCINOG MUTAGEN
[4]   Dual specificity phosphatase 4 gene expression in association with triple-negative breast cancer outcome [J].
Baglia, Michelle L. ;
Cai, Qiuyin ;
Zheng, Ying ;
Wu, Jie ;
Su, Yinghao ;
Ye, Fei ;
Bao, Ping-Ping ;
Cai, Hui ;
Zhao, Zhiguo ;
Balko, Justin ;
Zheng, Wei ;
Lu, Wei ;
Shu, Xiao-Ou .
BREAST CANCER RESEARCH AND TREATMENT, 2014, 148 (01) :211-220
[5]   Inhibition of protein phosphatase 2A sensitizes pancreatic cancer to chemotherapy by increasing drug perfusion via HIF-1α-VEGF mediated angiogenesis [J].
Bai, Xueli ;
Zhi, Xiao ;
Zhang, Qi ;
Liang, Feng ;
Chen, Wei ;
Liang, Chao ;
Hu, Qida ;
Sun, Xu ;
Zhuang, Zhengping ;
Liang, Tingbo .
CANCER LETTERS, 2014, 355 (02) :281-287
[6]   Activation of MAPK Pathways due to DUSP4 Loss Promotes Cancer Stem Cell-like Phenotypes in Basal-like Breast Cancer [J].
Balko, Justin M. ;
Schwarz, Luis J. ;
Bhola, Neil E. ;
Kurupi, Richard ;
Owens, Phillip ;
Miller, Todd W. ;
Gomez, Henry ;
Cook, Rebecca S. ;
Arteaga, Carlos L. .
CANCER RESEARCH, 2013, 73 (20) :6346-6358
[7]   Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance [J].
Balko, Justin M. ;
Cook, Rebecca S. ;
Vaught, David B. ;
Kuba, Maria G. ;
Miller, Todd W. ;
Bhola, Neil E. ;
Sanders, Melinda E. ;
Granja-Ingram, Nara M. ;
Smith, J. Joshua ;
Meszoely, Ingrid M. ;
Salter, Janine ;
Dowsett, Mitch ;
Stemke-Hale, Katherine ;
Gonzalez-Angulo, Ana M. ;
Mills, Gordon B. ;
Pinto, Joseph A. ;
Gomez, Henry L. ;
Arteaga, Carlos L. .
NATURE MEDICINE, 2012, 18 (07) :1052-+
[8]   A Novel Coumarin-Quinone Derivative SV37 Inhibits CDC25 Phosphatases, Impairs Proliferation, and Induces Cell Death [J].
Bana, Emilie ;
Sibille, Estelle ;
Valente, Sergio ;
Cerella, Claudia ;
Chaimbault, Patrick ;
Kirsch, Gilbert ;
Dicato, Mario ;
Diederich, Marc ;
Bagrel, Denyse .
MOLECULAR CARCINOGENESIS, 2015, 54 (03) :229-241
[9]   BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin [J].
Bansal, Nisha ;
Marchion, Douglas C. ;
Bicaku, Elona ;
Xiong, Yin ;
Chen, Ning ;
Stickles, Xiaomang B. ;
Al Sawah, Entidhar ;
Wenham, Robert M. ;
Apte, Sachin M. ;
Gonzalez-Bosquet, Jesus ;
Judson, Patricia L. ;
Hakam, Ardeshir ;
Lancaster, Johnathan M. .
JOURNAL OF GYNECOLOGIC ONCOLOGY, 2012, 23 (01) :35-42
[10]   Sodium Selenite Increases the Activity of the Tumor Suppressor Protein, PTEN, in DU-145 Prostate Cancer Cells [J].
Berggren, Margareta ;
Sittadjody, Sivanandane ;
Song, Zuohe ;
Samira, Jean-Louis ;
Burd, Randy ;
Meuillet, Emmanuelle J. .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2009, 61 (03) :322-331